Skip to main content
Fig. 5 | BMC Medical Genomics

Fig. 5

From: LncRNA weighted gene co-expression network analysis reveals novel biomarkers related to prostate cancer metastasis

Fig. 5

Hub lncRNAs validation in TCGA data. AThe expression levels of FTX, AC005261.1, NORAD, LINC01578, ZFAS1, EBLN3P, THUMPD3-AS1, and GAS5 in non-metastatic and metastatic groups. B RFS curve of the 8 hub lncRNAs in PCa based on Kaplan–Meier analysis and log-rank test. Patients were divided into the high expression level group and the low expression level group based on the median value in non-metastatic or metastatic group

Back to article page